Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Oligometastatic Disease Market Forecast DelveInsight's Oligometastatic Disease Market report offers an in-depth understanding of the epidem ...

A Case Series of 9 Patients A 2022 International Survey on the Status of Prostate Cancer Theranostics 68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate ...

Ten Year Treatment Outcomes of Radical Prostatectomy vs External Beam Radiation Therapy vs Brachytherapy for 1,503 Patients with Intermediate Risk Prostate Cancer Comparison of definitive therapy of ...

Skarpakazoo (Taupō) will join forces with locals Spikey & Pray for Summer and Dead Empire (Tauranga) for a one-off gig.

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

It’s tough for a man to know what to do following a diagnosis of prostate cancer.The treatment is often worse than the ...

Distant-stage prostate cancer increased and mortality rates plateaued throughout California during the 2010s, accordin ...

A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.

Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...

A recent study from researchers at Vanderbilt University and the University of Michigan has demonstrated that a simple at-home urine test can accurately screen for prostate cancer. The findings, ...

increases risk of adult prostate cancer, according to a new ... Jan. 3, 2025 — In April 2021, a provision in the 21st Century Cures act took effect which required that all medical test results ...